Enlivex (ENLV) Return on Sales (2022 - 2025)
Enlivex (ENLV) posted quarterly Return on Sales of 0.01% for Q1 2025, little changed year-over-year from 0.01% in Q1 2024, and up 345.5% quarter-over-quarter from 0.0% in Q4 2024.
Enlivex (ENLV) Return on Sales (2022 - 2025) Analysis & Trends
Enlivex's Return on Sales history runs 4 years deep, the most recent figure standing at 0.01% for Q1 2025.
- In Q1 2025, Return on Sales changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2025 stood at 0.01% (up 21.0% YoY), while the FY2024 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Sales for Q1 2025 stood at 0.01%, up from 0.0% in the prior quarter.
- The five-year high for Return on Sales was 0.01% in Q1 2025, with the low at 0.01% in Q4 2023.
- The 4-year median for Return on Sales is 0.01% (2023), against an average of 0.0%.
- Peak annual rise in Return on Sales reached 0 bps in 2023, while the deepest fall reached 0 bps in 2023.
- Enlivex's Return on Sales stood at 0.01% in 2022, then sank by 174 bps to 0.01% in 2023, then climbed by 28 bps to 0.0% in 2024, then jumped by 346 bps to 0.01% in 2025.
- Business Quant data shows ENLV's Return on Sales at 0.01% in Q1 2025, 0.0% in Q4 2024, and 0.01% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 0.00% |
| 10 | Enlivex | 4.49 Mn | -1.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | 0.00% |
| Mar 31, 2024 | 0.01% |
| Dec 31, 2023 | -0.01% |
| Mar 31, 2023 | 0.01% |
| Mar 31, 2022 | 0.01% |